Metropolis Healthcare rises on higher quarterly revenue
Oct 7 (Reuters) - ** Shares of Metropolis Healthcare METP.NS rise 2.7% to 2,127.80 rupees ** Co reports 23% Y/Y climb in September quarter consolidated revenue ** Stock rated "buy" on avg by 16 analysts; median PT at 2,240 rupees - data compiled by LSEG ** YTD, stock up 2.5% vs larger rival Dr Lal Path Labs' DLPA.NS nearly 6% climb (Reporting by Mridula Kumar) ((Mridula.Kumar@thomsonreuters.com;))
Recent news on Metropolis Healthcare
See all newsBrief: Metropolis Healthcare Q2fy27 Revenue Grew About 15% Year-On-Year
Brief: Metropolis Health Says Unit Metropolis Quality Solutions Enters Share Subscription And Shareholder's Agreements
Brief: Metropolis Health June-Quarter Consol Net Profit 566.7 Million Rupees
Brief: Metropolis Health Declares 2Nd Interim Dividend Of 1 Rupee Per Share
Brief: Metropolis Health March-Quarter Consol Net Profit 509 Million Rupees